Open original FDA record ↗Recall record
- FDA identifier
- Z-2438-2019
- Company in FDA record
- Becton Dickinson & Co.
- FDA record creation date
- Aug 30, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
An anomaly is present in InoqulA / InoqulA+ software version 20.3, has the potential to cause a mismatch between a specimen and plate
Source facts
- Action
- BD initiated a field correction via letter on July 26, 2019 and BD Technical Service has completed the correction (software upgrade) for all six (6) affected US customers. Letter identifies issue, health risk and customer action to take. BD is in the process of evaluating the log files of customers using the InoqulATM / InoqulA+TM software version 20.3 to determine if any users potentially experienced mismatch between a specimen and plate. BD will contact all customers using InoqulATM / InoqulA+TM software version 20.3 to provide the outcome of this evaluation. Contact: BD Customer/Technical Support 800-638-8663 Monday Friday between 7:00am and 7:00pm (EST) in the United States. For customers outside the US, contact your local BD representative or distributor.
- Initiated
- 2019-07-26
- Root cause
- Software design
- Terminated
- 2019-12-06
- Distribution
- Illinois, Iowa, Missouri, New York, Ohio, Tennessee World Wide (5): Singapore, Taiwan, France, Netherlands
- Recall number
- Z-2438-2019
- Recall status
- Terminated
- CDRH record ID
- 175593
- FDA record created
- 2019-08-30
- Recall event number
- 83513